Iris nertschinskia, an ornamental plant, is utilized in traditional East Asian medicine for the treatment of skin diseases. However, the biological activity underlying its therapeutic effects remains to be established. In this study, we investigated the anti-tumor effect of the plant extract on McF7 human breast cancer cells. An ethanol extract of Iris nertschinskia triggered cell death in a dose-dependent manner. Moreover, treatment with the extract promoted p53 phosphorylation in McF7 cells. Increased phosphorylation of p53, in turn, led to induction of Bax protein, a key regulator of p53-dependent apoptotic cell death, as well as of caspase-7 cleavage in McF7 cells. consistently, cells treated with p53-specific siRNA or the caspase inhibitor, Z-VAD, resisted apoptotic cell death induced by the Iris nertschinskia extract. Our results suggest that p53 sensitizes tumor cells to the ethanol extract of Iris nertschinskia by Bax protein induction and caspase-dependent apoptosis.
Introduction
A number of natural compounds from oriental herbs and plants have been isolated for the treatment of diverse human diseases (1) (2) (3) (4) (5) . In particular, a variety of Iris species are potent anti-cancer agents (6) (7) (8) (9) (10) . For example, Iris tectorum, introduced as a remedy in the first Chinese monograph on herbal medicine, induces cell cycle arrest and apoptosis in McF7 and c32 cell lines (6, 7) . Additionally, Iris germanica and Iris missouriensis display anti-tumor activities (9, 10) .
Iris nertschinskia is an ornamental plant found in Korea, china, Japan and Eastern Siberia. The plant is traditionally used in East Asian medicine for the treatment of sore throat, skin disease, depilatory disease, and canities. However, no therapeutic effects of this plant on cancer have been reported to date.
Extracts from plants or herbs induce apoptosis (programmed cell death), in cancer cells (11) (12) (13) . Apoptosis is triggered by cellular stress, which may affect organelles, including the nucleus, endoplasmic reticulum (ER), lysosomes and mitochondria (14) . The tumor suppressor protein p53, plays a key role in the response of cellular organelles to stress (15, 16) . p53 protein triggers apoptosis via changes in mitochondrial membrane permeabilization through induction of transcriptional targets, such as Bax (17, 18) . Additionally, expression of functional p53 in various p53-deficient cancer cell lines results in apoptosis (19, 20) . Evidently, p53 is an important factor in regulating the responses of host cells, and thus is applicable to cancer therapy (15, 17) .
In this study, we investigated the anti-tumor effects of an ethanol extract of Iris nertschinskia and the underlying mechanisms involved. In particular, we focused on the functional status of p53. Initially, we observed that the ethanol extract of Iris nertschinskia induced apoptosis in McF7 cells expressing the wild-type p53 gene. This finding led us to investigate its effects on p53 functional status. Our data clearly indicate that ethanol extracts of Iris nertschinskia exert p53-dependent chemosensitivity.
Materials and methods
Cell culture. McF7, a human breast carcinoma cell line, was maintained in dMEM supplemented with 10% FBS (Life Technologies, Inc., grand Island, Ny) and penicillinstreptomycin (50 U/ml).
Cell cytotoxicity. cell viability was determined using trypan blue exclusion by counting at least 500 cells in each culture. cells were treated with 10, 20, 50 or 100 µg/ml of the Iris nertschinskia ethanol extract for 24 h, and live and dead cells were counted.
Preparation of ethanol extracts of Iris nertschinskia. Iris nertschinskia (50 g) was extracted with ethanol (100%, 500 ml) for 18 h at RT to produce 24 g of solid extract. The ethanol extract was condensed by decompression concentration and suspended in DW. The suspended extract was frozen at -70˚C and dried. The resulting powder, a yellow solid, was suspended into dMSO.
HPLC and MS analysis. The HPLc system consisted of two L-7100 pumps (Hitachi, Japan) coupled with an L-4000 UV detector (Hitachi) and the Sedex evaporative light scattering detector (ELSd, Sedere, France). Phenomenex gemini c 18 columns were used for the isolation and purity assessment of the compounds (a 5 µm, 250x10 mm and a 5 µm, 250x4.6 mm column, respectively). MS spectra of the isolated compounds were recorded using the JMS-700 Mass Spectrometer (Jeol, Japan).
RNA interference.
Human breast cancer cells were transiently transfected with scrambled siRNA (5'-gcc ggg UgU UUc UAg gAA Agg AUU U-3') (Samchully Pharm co. Ltd.) or p53 siRNA (5'-gAc Tcc AgT ggT AAT cTA c-3') using Lipofectamine™ RNAiMAX (Invitrogen, carlsbad, cA).
Cell cycle analysis. For dNA content analysis, 1x10 6 cells were harvested by trypsinization and fixed by rapid submersion in 1 ml cold 70% ethanol. After fixation at -20˚C for at least 1 h, cells were pelleted, resuspended in 1 ml staining solution (50 µg/ml propidium iodide, 50 µg/ml RNase, 0.1% Triton X-100 in citrate buffer, pH 7.8), and washed with PBS. Fluorescence-stained cells were transferred to polystyrene tubes with cell strainer caps (Falcon), and sorted using a fluorescence-activated cell sorter (FAcS) (Bd FAcScalibur™).
Western blot analysis. cell lysates were prepared with RIPA lysis buffer (50 mM Tris-Hcl, pH 7.5, 50 mM Nacl, 1 µM EgTA, 1% Triton X-100) containing a protease inhibitor cocktail. Protein concentrations in extracts were determined using the Bradford assay, and 30 µg of total cell protein per sample were separated by SdS-PAgE and transferred to a PolyScreen membrane (NEN, Boston, MA). Membranes were blocked with 5% nonfat dry milk in TBST buffer (20 mM Tris-Hcl, pH 7.4, 150 mM Nacl, 0.1% Tween-20) and probed with one of the following antibodies: anti-p53 (Santa cruz Biotechnology, Santa cruz, cA), anti-phospho-p53 (cell Signaling Technology, Beverly, MA), anti-γ-tubulin, anticaspase-7 and anti-Bax (Santa cruz Biotechnology). Following incubation with horseradish peroxidase-conjugated goat antimouse and goat anti-rabbit secondary antibodies, blots were developed with an enhanced chemiluminescence detection kit (Amersham, Buckinghamshire, UK).
Results

Ethanol extract of Iris nertschinskia induces cell death in the MCF7 cell line.
Initially, we examined the effects of the Iris nertschinskia extract on the McF7 human breast cancer cell line. cells were treated with various doses (10, 25, 50 or 100 µg/ml) of the plant extract. Interestingly, we observed a significant increase in cell death in extract-treated MCF7 cultures (Fig. 1A) . Flow cytometric analyses revealed a dramatic increase in the number of cells at the sub-g1 phase after exposure to high doses of the extract (50 or 100 µg/ml) (Fig. 1B) . However, cell cycle arrest rather than death was observed with the low doses (10 or 25 µg/ml). cells treated with low doses of the ethanol extract accumulated at the g1 phase (data not shown), implying that Iris nertschinskia exerts an anti-tumor effect through cell death induction in the human McF7 breast cancer cell line.
HPLC analysis of the Iris nertschinskia extract.
We performed HPLC and MS analyses to define the material in an ethanol extract of Iris nertschinskia. ELSD-HPLC analysis identified 10 peaks of which the 3, peak nos. 1, 3, and 10, had an inhibitory effect on cell proliferation of McF7 cells ( Fig. 2A) . Secondly, the 3 peaks were analyzed by gc-MS methods to identify the materials (Fig. 2B) . Interestingly, the following three compounds were identified; dihydrovallesiachotamine, [(15β,16E)-16,17,20,21-tetradehydro-16-(hydroxymethyl)-18- (Fig. 3A) , indicative of an association with p53-induced cell death. Accordingly, we monitored the expression patterns of Bax in cells treated with the extract. The Bax protein level in total lysates exposed to the extract was increased (Fig. 3B) . Earlier studies have shown that overexpression of Bax mediated by p53 results in translocation to the mitochondrial outer membrane, and subsequently, to mitochondrial dysfunction (25-27). Moreover, Bax induces cytochrome c release that forms an apoptosome with Apaf-1 and procaspase-9, leading to activation of the caspase cascade (28) (29) (30) . Next, we examined the changes in caspase-7 in McF7 cells depleted of caspase-3 or -8 after treatment with the extract (31) . Both intermediate and cleaved forms of caspase-7 ( Fig. 3B) as well as caspase-9 (data not shown) were present in cells treated with ethanol extracts of Iris nertschinskia. These results suggest that apoptosis induced by the plant extract is associated with the functional status of p53 and its target molecules.
The ethanol extract of Iris nertschinskia induces p53-dependent apoptotic cell death.
To confirm that apoptotic cell death induced by the ethanol extract of Iris nertschinskia in McF7 cells is correlated with functional p53, we examined the effects of silencing endogenous wild-type p53 in McF7 cells using small interfering RNAs (siRNAs). cells were transiently transfected with p53 siRNA or scrambled siRNA constructs, followed by treatment with ethanol extracts of Iris nertschinskia in a dose-dependent manner (Fig. 4) . Transfection with p53 siRNA suppressed apoptosis induced by the ethanol extract of Iris nertschinskia, whereas scrambled siRNA had no effect (Fig. 4A) . To further confirm these results, we evaluated the protein levels of cleaved caspase-7 and Bax. Expression of Bax and cleavage of caspase-7 were suppressed in p53 siRNAtreated, but not in scramble siRNA-treated cells (Fig. 4B) . These results are in accordance with the theory that apoptosis induced by an ethanol extract of Iris nertschinskia is related to the functional status of p53 in McF7 cells. Figs. 3B and 4B , the ethanol extract of Iris nertschinskia promoted cleavage of caspase-7 in McF7 cells depleted of caspase-3 (31) . For further confirmation of these results, we examined the effects of the pan-caspase inhibitor, Z-VAD. Cells were pre-treated with 100 µM Z-VAD, followed by exposure to the extract. Treatment with Z-VAD significantly suppressed apoptotic cell death induced by the plant extract (Fig. 5A) . Moreover, changes in caspase-7 were investigated using Western blot analysis. Formation of cleaved (20 kda) and intermediate caspase-7 (35 kda) was clearly inhibited (Fig. 5B) , implying that the ethanol extract of Iris nertschinskia induces caspase-dependent apoptosis in McF7 cells.
The ethanol extract of Iris nertschinskia induces caspasedependent apoptotic cell death. As shown in
Discussion
In this study, we have shown that an ethanol extract of Iris nertschinskia induces apoptotic cell death in the McF7 human breast cancer cell line. Furthermore, the Iris nertschinskia extract stimulates phosphorylation of p53 at Ser-15, leading to overexpression of Bax protein and caspase-7 cleavage in McF7 cells. Importantly, transfection of p53 siRNA in cells suppresses apoptosis induced by the plant extract and alters both Bax protein and caspase-7 levels. It appears that the Iris nertschinskia extract confers enhanced sensitivity to cells with functional p53, suggesting that the functional p53 status is correlated with the underlying mechanism of apoptosis.
The major effect of the treatment of McF7 cells with high concentrations (50 or 100 µg/ml) of Iris nertschinskia was apoptotic cell death ( Fig. 1) while that of low doses (10 or 25 µg/ml) was to promote accumulation of cells at the g1 phase of the cell division cycle and to induce apoptosis (data not shown). This cellular phenomenon following treatment with low doses of the extract may be related to the functional status of p53. Several studies have shown that p53 regulates a variety of cellular responses, including cell cycle arrest and apoptosis, after exposure to stress (15, 16, 32) . As shown in Fig. 3 , phosphorylation of p53 was additionally stimulated after treatment with low doses of the ethanol extract of Iris nertschinskia. We are currently investigating the detailed mechanisms underlying cell cycle arrest induced by the plant extract at lower doses.
Since the function of p53 in response to cellular stress has generally been established based on its role in the dNA damage response pathway (32), we focused on the functional status of p53. The ethanol extract of Iris nertschinskia induced apoptosis in McF7 cells containing wild-type p53, as well as phosphorylation of p53 (Figs. 1 and 3 ). These events were significantly suppressed in p53 siRNA-treated cells (Fig. 4) . consequently, target molecules, such as Bax protein and caspase-7, were clearly affected. Thus, it appears likely that p53 activation in Iris nertschinskia-treated cells is sufficient to elicit a full apoptotic response through overexpression of Bax protein and cleavage of caspase-7 (Figs. 3 and 4) . We speculate that the anti-tumor effects of the ethanol extract of Iris nertschinskia on cancer cell lines are correlated with functional status of p53. To further confirm this phenomenon, we are investigating a variety of cancer cell lines that have p53 function. Our findings suggest that the Iris nertschinskia extract induces apoptotic cell death through activation of p53, and subsequently, induction of Bax protein and caspase-7 cleavage in McF7, a human breast cancer cell line, thus presenting an attractive cancer treatment option. (A) cells were pretreated with 100 mM Z-VAD, a pan-caspase inhibitor, followed by the indicated doses of the Iris nertschinskia extract for 24 h. cell death was determined as for Fig. 1. (B) Analysis of the effect of Z-VAD on cells by Western blotting using an anticaspase-7 antibody. γ-tubulin was used as the loading control.
